| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Obstetrics and Gynecology, and Physiology, Virginia Commonwealth University, Richmond, Virginia 23298-0034, USA; and
* Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602, USA
1Correspondence: Virginia Commonwealth University, Department of Obstetrics and Gynecology, Sanger Hall, Rm. 11–039, 1101 E. Marshall St., Richmond, VA 23298-0034, USA. E-mail: swwalsh{at}hsc.vcu.edu
We determined placental tissue levels, production rates, and secretion rates of isoprostanes for placentas obtained from women with normal pregnancies and women with preeclampsia, a hypertensive disorder of pregnancy. Isoprostanes are markers of oxidative stress that exert biological actions such as vasoconstriction. Placental tissue was rinsed and immediately frozen in liquid nitrogen to determine tissue levels of total and free isoprostane. Placental tissue pieces were also incubated in serum-free DMEM for 48 h at 37°C in 95% air/5% CO2 to determine production rates. Isolated placental cotyledons were perfused for the determination of secretion rates. All samples were analyzed by EIA for isoprostane using an antibody specific for 8-Iso-PGF2 (15-F2t-IsoP). In addition, medium samples were analyzed for malondialdehyde (MDA), a breakdown product of lipid peroxidation. We found that tissue levels of free isoprostane and total isoprostane (free plus esterified forms) were significantly higher for preeclamptic placentas than for normal placentas. Concentrations of isoprostane and MDA in the medium increased progressively during 48 h of incubation of placental explants. At 48 h of incubation, the mean concentrations of both isoprostane and MDA were significantly higher for the placentas from preeclamptic women than for the placentas from normal pregnant women. Concentrations of MDA were highly correlated with those of isoprostane. Induction of oxidative stress with xanthine plus xanthine oxidase increased placental production of isoprostane by normal tissue to a level similar to that of preeclamptic tissue. Placental secretion of isoprostane was eightfold greater toward the maternal side of the placenta than toward the fetal side, and was increased sixfold on the maternal side and twofold on the fetal side by inducing oxidative stress with t-butyl hydroperoxide. This study presents new information that isoprostanes are formed and secreted by the human placenta and provides convincing evidence that oxidative stress and lipid peroxidation are abnormally increased in placentas of preeclamptic women.—Walsh, S. W., Vaughan, J. E., Wang, Y., Roberts, L. J., II. Placental isoprostane is significantly increased in preeclampsia.
Key Words: placenta • malondialdehyde • oxidative stress • isoprostanes
This article has been cited by other articles:
|
|
 |
|
  S. GULLER, Y. Y. MA, H.-H. FU, G. KRIKUN, V. M. ABRAHAMS, and G. MOR The Placental Syncytium and the Pathophysiology of Preeclampsia and Intrauterine Growth Restriction: A Novel Assay to Assess Syncytial Protein Expression Ann. N.Y. Acad. Sci., April 1, 2008; 1127(1): 129 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Meziani, A. Tesse, S. Welsch, H. Kremer, M. Barthelmebs, R. Andriantsitohaina, F. Schneider, and A. Gairard Expression and Biological Activity of Parathyroid Hormone-Related Peptide in Pregnant Rat Uterine Artery: Any Role for 8-Iso-Prostaglandin F2{alpha}? Endocrinology, February 1, 2008; 149(2): 626 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Friel, P. G. Hynes, D. J. Sexton, T. J. Smith, and J. J. Morrison Expression Levels of mRNA for Rho A/Rho Kinase and Its Role in Isoprostane-Induced Vasoconstriction of Human Placental and Maternal Vessels Reproductive Sciences, February 1, 2008; 15(2): 179 - 188. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Tesse, F. Meziani, E. David, N. Carusio, H. Kremer, F. Schneider, and R. Andriantsitohaina Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H520 - H525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Walsh What Causes Endothelial Cell Activation in Preeclamptic Women? Am. J. Pathol., October 1, 2006; 169(4): 1104 - 1106. [Full Text] [PDF]
|
|
|
|
|
|
F. Meziani, A. Tesse, E. David, M. C. Martinez, R. Wangesteen, F. Schneider, and R. Andriantsitohaina Shed Membrane Particles from Preeclamptic Women Generate Vascular Wall Inflammation and Blunt Vascular Contractility Am. J. Pathol., October 1, 2006; 169(4): 1473 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gago-Dominguez, J. E. Castelao, M. C. Pike, A. Sevanian, and R. W. Haile Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2829 - 2839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. O Scholl, M. Leskiw, X. Chen, M. Sims, and T P. Stein Oxidative stress, diet, and the etiology of preeclampsia Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1390 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nash, M. Olovsson, and U. J. Eriksson Placental Dysfunction in Suramin-Treated Rats: Impact of Maternal Diabetes and Effects of Antioxidative Treatment Reproductive Sciences, April 1, 2005; 12(3): 174 - 184. [Abstract] [PDF]
|
|
|
|
|
|
L. POSTON, M. RAIJMAKERS, and F. KELLY Vitamin E in Preeclampsia Ann. N.Y. Acad. Sci., December 1, 2004; 1031(1): 242 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lappas, M. Permezel, and G. E. Rice Release of Proinflammatory Cytokines and 8-Isoprostane from Placenta, Adipose Tissue, and Skeletal Muscle from Normal Pregnant Women and Women with Gestational Diabetes Mellitus J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5627 - 5633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. M. Raijmakers, R. Dechend, and L. Poston Oxidative Stress and Preeclampsia: Rationale for Antioxidant Clinical Trials Hypertension, October 1, 2004; 44(4): 374 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. G. I. Thiele, K. E. Niezen-Koning, A. H. van Gennip, and J. G. Aarnoudse Increased Plasma Carnitine Concentrations in Preeclampsia Obstet. Gynecol., May 1, 2004; 103(5): 876 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Holthe, A. C. Staff, L. N. Berge, and T. Lyberg Leukocyte Adhesion Molecules and Reactive Oxygen Species in Preeclampsia Obstet. Gynecol., May 1, 2004; 103(5): 913 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Alzoghaibi, S. W. Walsh, A. Willey, D. R. Yager, A. A. Fowler III, and M. F. Graham Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites Am J Physiol Gastrointest Liver Physiol, April 1, 2004; 286(4): G528 - G537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dechend, C. Viedt, D. N. Muller, B. Ugele, R. P. Brandes, G. Wallukat, J.-K. Park, J. Janke, P. Barta, J. Theuer, et al. AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase Circulation, April 1, 2003; 107(12): 1632 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Hermenegildo, M. C. Garcia-Martinez, J. J. Tarin, and A. Cano Estradiol reduces F2alpha -isoprostane production in cultured human endothelial cells Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2644 - H2649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.M. Rahman and J. Wendon Severe hepatic dysfunction in pregnancy QJM, June 1, 2002; 95(6): 343 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Barden, J. Ritchie, B. Walters, C. Michael, J. Rivera, T. Mori, K. Croft, and L. Beilin Study of Plasma Factors Associated With Neutrophil Activation and Lipid Peroxidation in Preeclampsia Hypertension, October 1, 2001; 38(4): 803 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-H. Hung, J. N. Skepper, and G. J. Burton In Vitro Ischemia-Reperfusion Injury in Term Human Placenta as a Model for Oxidative Stress in Pathological Pregnancies Am. J. Pathol., September 1, 2001; 159(3): 1031 - 1043. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
